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1. Introduction 
Glaucoma with or without elevated intraocular pressure (IOP) leads to the loss of retinal 
ganglion cells and the visual fields loss. Most studies of glaucomatous conditions have dealt 
with the pathophysiology within the retina. In many cases, retinal ganglion cell death 
continues after medical or surgical management of elevated IOP. Relatively little attention 
has been given to the functional consequences of the remaining retinal ganglion cells 
following normalized intraocular pressure. Here we review the studies dealing with loss of 
visual acuities and contrast sensitivities of the glaucomatous retina with changes that follow 
the dendritic arbors of remaining ganglion cells and compare with the adaptive changes 
observed in the terminal areas of the optic axons in the brain visual centers. 
2. Background 
Glaucoma is the most common neurodegenerative disease of the eyes, leading to the 
blindness. The loss of vision in glaucoma has been attributed to the retinal ganglionic cell 
death (RGCs) and optic nerve axonal loss. In a recent study, advanced glaucoma 
intervention study, the relationship between intraocular pressure control and the visual 
field deficits has been established (1). This report has established the role of elevated IOP, in 
clinical trials, to the initiation of glaucoma and further elaborated that reduction of IOP can 
reduce the progressive vision loss in glaucomatous patients.  
In the pathology of the glaucoma, visual field losses first occur in the peripheral retina and 
progressively lead to the loss of all vision and complete blindness. The main therapy for the 
treatment of glaucoma has been the reduction of IOP that stabilizes the vision loss. 
However, in certain population, the visual loss continues in spite of the reduction of IOP.  
The death of RGCs in glaucoma is primarily apoptotic in experimental animals (2, 3) and in 
Human (4). The exact mechanism, which initiates the cascade of death signals in RGC of 
glaucomatous eye, is unclear. Similarly, how the elevation of IOP translates or triggers 
changes in either RGC or its effect to the optic disc and/or the optic axons is uncertain. 
Actually over the past 20 years, more efforts have been made in searching for the perfect 
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model that replicate human disease yet nothing close to human disease process has emerged 
in experimental animal models. However, these efforts have led to myriad theories of the 
initiation of changes in the prelaminar optic axons supporting the assumptions that optic 
axons are injured first followed by the death of RGCs. Similarly data exist that leads one to 
believe that RGCs are directly affected by elevated IOP.  
Relatively less efforts has been made in deciphering how the pressure triggers changes in 
cells other than RGCs. In animal models of glaucoma, activation of micoglia leads to 
proliferation and hypertrophy, visible within hours after the initial insult (5). The mechanisms 
of activation, proliferation, and hypertrophy are not understood. In glaucomatous eye, 
either the optic nerve or the retina initiates changes in microglia that have been known to 
trigger the formation of reactive oxygen species. The reactive oxygen species activate 
nuclear factor kappa B (NFKβ), which then results in the expression of proinflammatory 
cytokines. Persistence of these factors leads to the peroxidation of lipid and the activation of 
apoptotic neuronal death pathways. Speculations regarding such a role for microglia in 
glaucoma have been made, although no definite answers have yet emerged.  
Similarly, other glial cells, such as astrocytes, become hypertrophied and have enlarged end 
feet at the retinal blood vessels in glaucoma.  
It has also been reported that astrocyte migration occurs in response to neuronal injury 
through the action of myriad growth factors, such as epidermal growth factor (6); cytokines, 
such as tumor necrosis factor (TNF-α) and interleukin 1 alpha (IL-1α) (7); and other 
mediators, such as adenosine triphosphate (ATP) (8). This migration is considered an 
important component in the remodeling of the optic nerve head in glaucoma (9). Reactive 
astrocytes migrate from the cribriform plates into the nerve bundles and synthesize 
neurotoxic mediators such as nitric oxide (NO) and TNF-α, which may be released near the 
axons causing neuronal damage (10, 11). Agents that inhibit the migration of astrocytes by 
transforming growth factor B (TGFβ) and myosin light chain kinase pathways were 
suggested for glaucoma treatment (12). 
Müller cells have also been shown to respond to growth factors and cytokines (13), though 
their role in initiating RGC death in glaucoma is unclear.  
Recent evidence suggests that metabolic stress to astrocytes releases ATP which leads to the 
propagation of calcium waves causing axonal loss (14). Reactive microglia then follows the 
gradient of ATP to remove the axonal debris. The marked activation of microglia in the 
retina, optic nerve, and tract was postulated to accompany ongoing axonal degeneration. 
The degree of activation in the optic nerve correlated with axonal damage (14). Interestingly, 
as microglia is the major cell population in the central nervous system with the potential to 
act as antigen-presenting cell, upregulated major histocompatibility complex (MHC) 
antigens were not sufficient to stimulate significant T-cell infiltration in a mouse model of 
glaucoma (15,16).  
The steps of programmed cell death in glaucoma are similar to the steps in other 
neurodegenerative diseases, such as Alzheimer disease (AD), Parkinson disease, or even 
Huntington diseases. The agents that cause these diseases may be varied. There are certain 
common features, for example, the death of RGCs in glaucoma. In a recent article Crish et al. 
(16) showed that distal axonal injury appears early in mouse glaucoma, similar to the distal 
changes in AD and other neurodegenerative diseases. These authors showed the changes in 
axonal transports progress from the distal to the proximal end. The early changes showing 
the breakdown of optic axonal terminals were seen in superior colliculus followed by 
changes in the optic axons and finally in the retina. They further elaborated that in addition 
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to the failure or decrease in axonal transport (distal to the proximal area) the axonal terminal 
persisted in the colliculus. There is absolutely no information regarding this topic in Human 
glaucoma.  
Glaucomatous loss of RGC can cause neurodegeneration in the central visual pathways in 
animal (17) and in humans (18). Recent advance of functional magnetic resonance imaging 
(fMRI) provide functional assessment of visual changes in glaucoma patients, which 
correlated, well with the loss of visual field in the eye (19). Extensive reorganization of 
visual terminal area was detected in macular degeneration patients (20). In rat glaucoma 
model, the visual scotoma was not apparent in the tectum two to three weeks after surgery, 
and larger receptive fields on the periphery represent early signs of altered geometry of the 
retinal projections (21). It was further assumed that following the death of larger cells on the 
periphery, the remaining ganglion cells expanded their axonal arbors in the tectum leading 
to the enlarged receptive fields. The size of the receptive field correlated with the duration 
and magnitude of intraocular pressure elevation. In primates glaucoma RGC death leads to 
changes in the lateral geniculate nucleus (LGN) and visual area 1 where cell loss and the 
shrinkage of lateral geniculate nucleus was noted (23). Similar changes have been shown in 
the death of specific cell types in the LGN (22,24,28).  
In spite of massive literature that has emerged in the past decade regarding glaucoma, we 
are still uncertain regarding the initiation of RGC death. Relatively little attention has been 
given regarding the remaining RGC’s function following medical or surgical intervention to 
reduce the IOP and subsequent RGC death. In addition to observed scotoma, do remaining 
RGCs after glaucoma IOP management adapt to or show changes in their connectivity 
patterns to the terminal center of the optic axons in the brain? 
There are ample scientific evidences suggesting that retinal photoreceptor degeneration can 
lead to remodeling of the retinal circuitry (for a recent review see Ref. 25). It has been 
reported that even adult retina shows signs of neuronal plasticity as evidenced by the 
presence of hypertrophy and axonal sprouting in bipolar, amacrine and photoreceptors. 
In monkey retina with elevated IOP, retinal ganglion cells showed shrinkage of dendritic 
arbors (17). During non-human primate development, plasticity of RGC dendritic arbors 
and axonal terminals has been observed (25); however, there is a paucity of data supporting 
such claims in the adult retina. In monkey glaucomatous retina, there was no increase in 
RGC soma size or dendritic arborization (26); however, a decrease in the dendritic field sizes 
of the RGC was reported within 3-6 months of induced glaucoma. In monkeys, Smith et al. 
(27) reported visual deficits in long-term glaucoma as a consequence of RGC loss with no 
changes in the functional property of the surviving neurons. In addition, loss of some lateral 
geniculate neurons and reduction in the soma sizes of others were observed. 
2.1 Evaluation of recent findings 
In experimental rat glaucoma, ganglion, amacrine, and rod bipolar cell loss was observed 
within 5 weeks of elevated intraocular pressure (IOP), suggesting that inner nuclear layer 
cells of the retina were affected as well (36,37). We previously showed 3-4% RGC death per 
week in glaucomatous rats (29). The IOP elevation was induced by episcleral venous 
cauderization. In these animals, IOP usually returned to normal after 10-12 weeks of 
elevation, possibly due to revascularization. During the period of elevated IOP in the 
experimental eyes, the remaining ganglion cell soma increased in size of all RGC types. This 
increase in soma size can be attributed as a precursor to their death. Another possibility is 
derived from developmental studies on the retina that points to the fact that increase in  
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Fig. 1. The retinotopic projective maps in a normal rat when recorded from the electrode 
positions place on the contralateral superior colliculus. Figure on the left shows numbers  
1-16 are representative examples of the visually driven receptive field sizes form the tectum 
when driven by a normal eye. Receptive field sizes were between 12-25° degrees. The right 
visual field map shows visually driven receptive field sizes (positions 19-35) in glaucomatous 
eye that are almost doubled in size when compared to normal. In these topographic mapping 
there was no overlap of receptive fields in the normal eye mapping, however, experimental 
glaucomatous eye showed numerous overlapping receptive fields. The normal order of the 
map was degraded. Many other abnormalities were seen in other maps  
soma size of RGC is linked to the soma density. As in glaucomatous RGC, when the  cell 
number decreases, the remaining ganglion cells may hypertrophy. Upon the induction of 
elevated IOP in pigs using episcleral venous occlusion as in rats (32), Ruitz-Ederra et al. 
similarly showed an increase in the mean soma area of the remaining RGC (31). A recent 
study in rat glaucoma showed the neuroprotective effect on retinal ganglion cell survival 
following systemically administration of bromonidine and it further prevented the increase 
in soma sizes usually associated with RGC death (38). Additionally, because RGCs are 
ensheathed by Müller cell processes, these processes must change their milieus to allow the 
soma to increase in size. These findings stand in contrast to findings in the glaucomatous 
monkey retina, where all retinal ganglion cells shrink in size, perhaps due to the constraints 
of very tight Müller cell processes that may not allow expansion (30). Future studies must 
explore the possibility of ganglion cell dendritic arbor expansion following the breakdown 
of Müller cell ensheathment. 
In addition to soma size increases in rat RGCs, Ahmed et al. also showed the increase in the 
dendritic arbors of the remaining ganglion cells in glaucomatous eyes (28). Do these changes 
observed in remaining RGCs have compensatory effects on the target centers as well? 
Towards this goal visually evoked receptive fields were mapped onto the superior colliculus 
contralateral to the experimental glaucomatous eyes (21). 
Recent evidence from mouse and rat studies showed that the optic axonal terminal synapses 
degenerate from the distal to proximal direction and precede the degeneration and death of 
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RGCs (33-35). We theorize that the larger visual receptive fields in the superior colliculus of 
rats with elevated IOP may be the consequence of expanding terminals of the intact axons 
into spaces vacated by dying retinal axon terminals (22). Within 6-8 weeks of induced 
glaucoma, electrophysiological mapping showed no significant changes in receptive field 
sizes when recorded in the superior colliculus. Dramatic changes were not observed until  
4-10 months following IOP elevation (22).  
Visual receptive fields measured in the contralateral superior colliculus fall in the range of 
15 to 20° (Figure 1A) in normal animals. Receptive fields measured 4 months later in 
experimental animals with elevated IOP were in the range of 40 to 60° (Figure 1B). These 
observations indicate some adaptive changes. 
2.2 Changes in axonal terminal arbors 
Anatomical evidences for observed enlargement of receptive fields in experimental glaucoma 
point to the increase in the axonal terminal arbors of the remaining retinal ganglion cells 
axons in the contralateral superior colliculus. Figure 2 shows the morphology of RGC axonal 
terminal in the superior colliculus. The axons at proximal and distal portion of superior 
colliculus (Figure 2A and 2C) in the normal IOP animal are displayed. With elevation of IOP 
for 4 months, the axons at the same level were enlarged and more terminal branches were 
identified (Figure 2B and 2D). This suggests that surviving axons may occupy the territory 
of the dead axons.  
 
 
Fig. 2. Camera lucida drawing of the axonal arbor in the mid rostal (Fig. 2A) tectal region of 
a normal rat, total area of the terminal was 11250 μm2. In the glaucomatous animal, the area 
of terminal axonal arbor at similar location to the normal was 12480 μm2 (Fig. 2B). In the 
caudal tectum of normal rat, the area of the normal optic axonal terminal was 14290 μm2 
(Fig. 2C) whereas it was 18060 μm2 in glaucomatous side (Fig. 2D). It was also noted that 
these were less vericosities and relatively less dense boutons when compared to the normal 
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The functional consequences of the changes observed in glaucomatous animals following 
changes in RGC somas and dendritic arbors of the remaining ganglion cells and the axonal 
terminal arbors in the contralateral superior colliculus, as described above, were determined 
psychophysiologically in the experimental animals. Slow horizontal head and body rotation 
occurs in rats when the visual fields are rotated around them. These optomotor responses 
can be readily reproduced. When one eye is closed, only motion in the temporal to nasal 
direction for the contralateral eye evokes the tracking response. In these animals, visual 
acuity refers to the maximal spatial frequency capable of evoking an optomotor response. In 
a normal animal, the visual acuity of the right and left eyes is identical in monocular or 
binocular viewing conditions. In an experimental eye of elevated IOP, the visual acuity was 
significantly lower when compared to the control eye (p < 0.0005). In addition, the contrast 
sensitivity as a function of spatial frequency was also studied. At all spatial frequencies 
studied, the contrast sensitivity of the experimental eye was lower than the control eye  
(p < 0.0005) (39).  
2.3 Future directions 
The contrasting changes seen in studies involving rat and those involving human glaucoma 
are at first unsettling. We strongly believe that the following studies need to be undertaken 
in human.  
a. Longitudinal studies using optical coherence tomography (OCT) with adaptive optics 
to discern changes in different retinal cell types during the progression of glaucoma.  
b. Studies of the progression or regression of scotomas in human patients following 
management of elevated IOP either surgically and/or medically 
If there are documented changes, one can pursue the means to induce adaptive changes. At 
present one can only partially block the progression of glaucomatous scomota and one 
assumes that partial vision is better than no vision. We must therefore seek the new avenues 
to overcome our limitations.  
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